Uterine Perforation with the Levonorgestrel-Releasing Intrauterine Device: Analysis of Reports from Four National Pharmacovigilance Centres

By >   Sachs Bernhardt  

Drug Safety, Vol. 34, Iss. 1, 2011-01 ,pp. : 83-88

Adis International

Access to resources Recommend Favorite

Drug Interactions with Cholinesterase Inhibitors: An Analysis of the French Pharmacovigilance Database and a Comparison of Two National Drug Formularies (Vidal, British National Formulary)

By Tavassoli Neda   Sommet Agnes   Lapeyre-Mestre Maryse   Bagheri Haleh   Montrastruc Jean-Louis  

Drug Safety, Vol. 30, Iss. 11, 2007-01 ,pp. : 1063-1071

Adis International

Access to resources Recommend Favorite

Drug Fever: A Descriptive Cohort Study from the French National Pharmacovigilance Database

By Vodovar Dominique   LeBeller Christine   Mégarbane Bruno   Lillo-Le-Louet Agnes   Hanslik Thomas  

Drug Safety, Vol. 35, Iss. 9, 2012-09 ,pp. : 759-767

Adis International

Access to resources Recommend Favorite

Bisphosphonate‐related osteonecrosis of the jaw: data from the French national pharmacovigilance database

By  

Fundamental & Clinical Pharmacology, Vol. 30, Iss. 5, 2016-10 ,pp. : 450-458

John Wiley & Sons Inc

Access to resources Recommend Favorite

Corticosteroid-Associated Tendinopathies: An Analysis of the Published Literature and Spontaneous Pharmacovigilance Data

By Blanco Irene   Krähenbühl Stephan   Schlienger Raymond G.  

Drug Safety, Vol. 28, Iss. 7, 2005-01 ,pp. : 633-643

Adis International

Access to resources Recommend Favorite